| Adrafinil-induced orofacial dyskinesia. | |
| | |
MedLine Citation:
|
PMID: 15300665 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We describe the first case of orofacial abnormal movements induced by adrafinil, a vigilance promoting agent of the same pharmacological class as modafinil. The dyskinesias did not spontaneously recover despite adrafinil withdrawal for a 4-month period. They were secondly dramatically improved by tetrabenazine, a presynaptic dopaminergic depleting drug which was introduced after the 4-month adrafinil-free period. |
| | |
Authors:
|
Stéphane Thobois; Jing Xie; Helena Mollion; Isabelle Benatru; Emmanuel Broussolle |
Related Documents
:
|
7015825 - Renal manifestations of drug-induced systemic lupus erythematosus. 2300705 - Sequential morphological changes in chicken erythrocytes after in vivo and in vitro exp... 3179445 - Comparison of transferrin receptor-mediated endocytosis and drug-induced endocytosis in... 10502535 - Are there environmental forms of systemic autoimmune diseases? 2904695 - The therapeutic latency of neuroleptic drugs and nonspecific postjunctional supersensit... 3799535 - Tension headache treated by anti-inflammatory drug injected into gb 20 acupuncture point. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Movement disorders : official journal of the Movement Disorder Society Volume: 19 ISSN: 0885-3185 ISO Abbreviation: Mov. Disord. Publication Date: 2004 Aug |
Date Detail:
|
Created Date: 2004-08-09 Completed Date: 2004-12-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8610688 Medline TA: Mov Disord Country: United States |
Other Details:
|
Languages: eng Pagination: 965-6 Citation Subset: IM |
Copyright Information:
|
Copyright 2004 Movement Disorder Society |
Affiliation:
|
Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France. stephane.thobois@chu-lyon.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Anti-Dyskinesia Agents / therapeutic use Antihypertensive Agents / adverse effects* Dyskinesia, Drug-Induced / drug therapy, etiology* Humans Hydroxamic Acids / adverse effects* Hypertension / drug therapy Male Tetrabenazine / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Dyskinesia Agents; 0/Antihypertensive Agents; 0/Hydroxamic Acids; 58-46-8/Tetrabenazine; 63547-13-7/adrafinil |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ninhydrin sweat test: a simple method for detecting antibodies neutralizing botulinum toxin type A.
Next Document: Segmental dystonia induced by wearing glasses with a ribbon: an unusual case of a reverse sensory ge...